On Oct. 20, 2020, PerkinElmer announced that a research team at the National Center for Advancing Translational Sciences (NCATS), an arm of the National Institutes of Health (NIH), was able to efficiently and accurately screen 3,384 molecular entities and narrow them down to a field of 25 quality therapeutic compounds or ﾓhitsﾔ. The whole process, from assay development and optimization through screening, has been achieved in just a few months.